Se connecter Inscription gratuite

Alimera Sciences Ret. sur l'équité

Quel est le Ret. sur l'équité de Alimera Sciences?

Le Ret. sur l'équité de Alimera Sciences Inc. est -33.70%

Quelle est la définition de Ret. sur l'équité?



Le rendement des capitaux propres est une mesure de la rentabilité d'une entreprise par rapport à la valeur comptable des capitaux propres. Il est calculé en divisant le résultat net de l'exercice par le total des capitaux propres.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Ret. sur l'équité des entreprises dans Health Care secteur sur NASDAQ par rapport à Alimera Sciences

Que fait Alimera Sciences?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

Entreprises avec ret. sur l'équité similaire à Alimera Sciences